These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 24865286)
1. Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Yang X; Saito R; Nakamura T; Zhang R; Sonoda Y; Kumabe T; Forsayeth J; Bankiewicz K; Tominaga T Drug Deliv; 2016; 23(3):781-6. PubMed ID: 24865286 [TBL] [Abstract][Full Text] [Related]
2. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models. Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076 [TBL] [Abstract][Full Text] [Related]
3. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery. Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253 [TBL] [Abstract][Full Text] [Related]
4. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model. Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069 [TBL] [Abstract][Full Text] [Related]
5. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695 [TBL] [Abstract][Full Text] [Related]
6. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain. Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625 [TBL] [Abstract][Full Text] [Related]
7. Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy. Zhan W; Wang CH J Control Release; 2018 Sep; 285():212-229. PubMed ID: 30009891 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models. Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554 [TBL] [Abstract][Full Text] [Related]
9. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. Saito R; Krauze MT; Noble CO; Tamas M; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS J Neurosci Methods; 2006 Jun; 154(1-2):225-32. PubMed ID: 16472868 [TBL] [Abstract][Full Text] [Related]
10. Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors. Saucier-Sawyer JK; Seo YE; Gaudin A; Quijano E; Song E; Sawyer AJ; Deng Y; Huttner A; Saltzman WM J Control Release; 2016 Jun; 232():103-12. PubMed ID: 27063424 [TBL] [Abstract][Full Text] [Related]
11. Intraparenchymal ultrasound application and improved distribution of infusate with convection-enhanced delivery in rodent and nonhuman primate brain. Mano Y; Saito R; Haga Y; Matsunaga T; Zhang R; Chonan M; Haryu S; Shoji T; Sato A; Sonoda Y; Tsuruoka N; Nishiyachi K; Sumiyoshi A; Nonaka H; Kawashima R; Tominaga T J Neurosurg; 2016 May; 124(5):1490-500. PubMed ID: 26495939 [TBL] [Abstract][Full Text] [Related]
12. Convection enhanced delivery of chemotherapeutic drugs into brain tumour. Zhan W; Wang CH J Control Release; 2018 Feb; 271():74-87. PubMed ID: 29274437 [TBL] [Abstract][Full Text] [Related]
13. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285 [TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery in clinical trials. Hall WA; Rustamzadeh E; Asher AL Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423 [TBL] [Abstract][Full Text] [Related]